Target intelligence / Profile preview

TNF receptor-associated factor 6 mRNA 3'-untranslated region (TRAF6 mRNA 3'-UTR)

Target
TRAF6 mRNA 3'-UTR
Molecular classification
RNA, Messenger RNA regulatory element
01

Overview

The TNF receptor-associated factor 6 (TRAF6) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the TRAF6 transcript that governs the post-transcriptional expression of the TRAF6 protein (UniProt Q9Y4K3). TRAF6 itself is a key E3 ubiquitin ligase and adapter protein that mediates signaling from the Toll-like receptor (TLR), interleukin-1 receptor (IL-1R), and tumor necrosis factor receptor (TNFR) superfamilies, playing a central role in innate and adaptive immunity (Taganov et al., 2006, PNAS). The 3'-UTR contains specific binding sites for various microRNAs, most notably miR-146a, which act as negative feedback regulators to prevent over-activation of inflammatory pathways. Dysregulation of this regulatory region or the microRNAs that target it is associated with chronic inflammatory diseases, such as rheumatoid arthritis, as well as various malignancies and myeloid disorders where TRAF6 is overexpressed (Starczynowski et al., 2010, Nature Medicine). Therapeutic strategies targeting the TRAF6 mRNA 3'-UTR involve the use of microRNA mimics or antisense oligonucleotides to downregulate TRAF6 expression and dampen pathological signaling. Consequently, this region serves as a focal point for developing precision medicines aimed at modulating immune responses and inhibiting tumor progression.

Other names
TRAF6 3'-UTRTNF receptor-associated factor 6 3'-UTRTRAF6 three prime untranslated region
02

Mechanism of action

Regulatory molecules such as microRNAs or antisense oligonucleotides bind to specific sequences within the 3'-UTR to induce mRNA degradation or translational repression, thereby reducing the synthesis of the TRAF6 protein.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation regulationImmune responseSignal transduction
04

Disease associations

InflammationCancerAutoimmune diseaseOsteoporosisSepsis
05

Safety considerations

Off-target RNA bindingPotential for systemic immunosuppressionDelivery vehicle toxicityCompromised innate immune response to pathogens
06

Interacting drugs

miR-146a mimics

2 more in the full profile.

07

Biomarkers

TRAF6 protein expression levelsmiR-146a expression levels

Beyond the preview

Go deeper on TNF receptor-associated factor 6 mRNA 3'-untranslated region (TRAF6 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNF receptor-associated factor 6 mRNA 3'-untranslated region (TRAF6 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call